These innovative treatments, Semaglutide , represent a groundbreaking advancement in managing metabolic dysfunction and possibly associated disorders. They all are grouped as GLP-1 receptor stimulators, meaning they to emulate the natural GLP-1 hormone , boosting metabolic release and lowering hu